Ahmad FS, Kallen MA, Schifferdecker KE, Carluzzo KL, Yount SE, Gelow JM, Mccullough PA, Kimmel SE, Fisher ES, Cella D. Development and Initial Validation of the PROMIS®-Plus-HF Profile Measure. Circulation Heart Failure June 2019; 12(6): e005751.
Ailawadi G, Lim DS, Mack MJ, Trento A, Kar S, Grayburn PA, Glower DD, Wang A, Foster E, Qasim A, Weissman NJ, Ellis J, Crosson L, Fan F, Kron IL, Pearson PJ, Feldman T, EVERST II Investigators. One-Year Outcomes After MitraClip for Functional Mitral Regurgitation. Circulation Jan 2019; 139(1): 37-47.
Balmforth C, Simpson J, Shen L, Jhund PS, Lefkowitz M, Rizkala AR, Rouleau JL, Shi V, Solomon SD, Swedberg K, Zile MR, Packer M, McMurray JJV. Outcomes and Effect of Treatment According to Etiology in HFrEF: An Analysis of PARADIGM-HF. JACC: Heart Failure June 2019; 7(6): 457-465.
Baran DA, Grines CL, Bailey S, Burkhoff D, Hall SA, Henry TD, Hollenberg SM, Kapur NK, O’Neill WO, Ornato JP, Stelling K, Thiele H, van Diepen S, Naidu SS. SCAI clinical expert consensus statement on the classification of cardiogenic shock: This document was endorsed by the American College of Cardiology (ACC), the American Heart Association (AHA), the Society of Critical Care Medicine (SCCM), and the Society of Thoracic Surgeons (STS) in April 2019. Catheter Cardiovascular Interventions May 2019; Epub.
Barbin CM, Vasudevan A, Choi JW, McCullough PA, Schussler JM, Vallabhan RC, Stoler RC. Frequency of abnormal fractional flow reserve measurements among major coronary arteries. Cardiovascular Revascularization Medicine Feb 2019; 20(2): 143-146.
Blankenship JC, Choi JW, Das TS, McElgunn PM, Mukherjee D, Paxton LL, Piana R, Sauer JR, White CJ, Duffy PL. SCAI/ACVP expert consensus statement on cardiovascular catheterization laboratory economics: If the cath lab is your home, you should understand its finances: This statement was endorsed by the Alliance of Cardiovascular Professionals (ACVP) in April 2019. Catheterization and Cardiovascular Interventions 2019; In Press.
Brown K, Adams J, McCullough PA. Comparison of reflex, resistance training, and core activities using change in blood pressure over time after spontaneous coronary artery dissection. Baylor University Medical Center Proceedings Jan 2019; 32(1): 113-115.
Chalkley RA, Kim CW, Choi JW, Roberts WC, Schussler JM. Smeloff-Cuttler Mechanical Prosthesis in the Aortic Position for 40 Years. The American Journal of Cardiology May 2019; Epub.
Dawkins JD, Cedars AM, Schussler JM. Transulnar access for coronary intervention in a 23-year old with accelerated coronary atherosclerosis due to congenital aortic hypoplasia. Clinical Case Reports Jan 2019; 7(3): 435-437.
Dewan P, Rorth R, Jhund PS, Shen L, Raparelli V, Petrie MC, Abraham WT, Desai AS, Dickstein K, Kober L, Mogensen UM, Packer M, Rouleau JL, Solomon SD, Swedberg K, Zile MR, McMurray JJV. Differential Impact of Heart Failure with Reduced Ejection Fraction on Men and Women. Journal of the American College of Cardiology Jan 2019; 73(1): 29-40.
Dewan R, Rorth R, Jhund PS, Ferreira JP, Zannad F, Shen L, Kober L, Abraham WT, Desai AS, Dickstein K, Packer M, Rouleau JL, Solomon SD, Swedberg K, Zile MR, McMurray JJV, PARADIGM-HF and ATMOSPHERE Investigators. Income Inequality and Outcomes in Heart Failure: A Global Between-Country Analysis. JACC Heart Failure April 2019; 7(4): 336-346.
Dewan R, Jhund PS, Shen L, Petrie MC, Abraham WT, Atif Ali M, Chen CH, Desai AS, Dickstein K, Huang J, Kiatchoosakun S, Kim KS, Kober L, Lai WT, Liao Y, Mogensen UM, Oh BH, Packer M, Rouleau JL, Shi V, Sibulo AS Jr., Solomon SD, Sritara P, Swedberg K, Tsutsui H, Zile MR, McMurray JJV. Heart failure with reduced ejection fraction: comparison of patient characteristics and clinical outcomes within Asia and between Asia, Europe and the Americas. European Journal of Heart Failure May 2019; 21(5): 577-587.
Goyal A, Chatterjee K, Mathew RO, Sidhu MS, Bangalore S, McCullough PA, Rangaswami J. In-Hospital Mortality and Major Adverse Cardiovascular Events after Kidney Transplantation in the United States. CardioRenal Medicine Jan 2019; 9(1): 51-60.
Grayburn PA, Sannino A, Packer M. Proportionate and Disproportionate Functional Mitral Regurgitation: A New Conceptual Framework that Reconciles the Results of the MITRA-FR and COAPT Trials. JACC: Cardiovascular Imaging Feb 2019; 12(2): 353-362.
Grayburn PA, Chandrashekhar Y. Imaging Challenges in Tricuspid Regurgitation and Right Ventricular Failure. JACC: Cardiovascular Imaging April 2019; 12(4): 768-770.
Grayburn PA. The Challenge of Assessing Residual Mitral Regurgitation During MitraClip Procedures: Is 3-Dimensional Vena Contracta Area the Answer? JACC: Cardiovascular Interventions March 2019; 12(6): 592-594.
Grayburn PA. Multimodality Imaging of Suspected Mechanical Prosthetic Valve Obstruction: Importance of the Patient and the Clinical Context. JACC Cardiovascular Imaging Feb 2019; Epub.
Haase VH, Chertow GM, Block GA, Pergola PE, deGoma EM, Khawaja Z, Sharma A, Maroni BJ, McCullough PA. Effects of vadadustat on hemoglobin concentrations in patients receiving hemodialysis previously treated with erythropoiesis-stimulating agents. Nephrology Dialysis Transplantation Jan 2019; 34(1): 90-99.
House AA, Wanner C, Sarnak MJ, Pina IL, McIntyre CW, Komenda P, Kasiske BL, Deswal A, deFilippi CR, Cleland JGE, Anker SD, Herzog CA, Cheung M, Wheeler DC, Winkelmayer WC, McCullough PA, Conference Participants. Heart failure in chronic kidney disease : conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference. Kidney International June 2019; 95(6): 1304-1317.
McCullough PA. Treatment of Orthostatic Hypotension Due to Autonomic Dysfunction (Neurogenic Orthostatic Hypotension) in a Patient with Cardiovascular Disease and Parkinson’s Disease. Cardiology and Therapy Jan 2019; Epub.
McCullough PA, Mehta HS, Cork DP, Barker CM, Gunnarsson C, Mollenkopt S, Van Houten JV, Verta P. The healthcare burden of disease progression in medicare patients with functional mitral regurgitation. Journal of Medical Economics June 2019; Epub.
McCullough PA, Todoran TM, Brilakis ES, Ryan MP, Gunnarsson C. Rate of major adverse renal or cardiac events with iohexol compared to other low osmolar contrast media during interventional cardiovascular procedures. Catheter Cardiovascular Interventions Feb 2019; 93(2): E90-E97.
Myhre PL, Vaduganathan M, Claggett B, Packer M, Desai AS, Rouleau JL, Zile MR, Swedberg K, Lefkowitz M, Shi V, McMurray JJV, Solomon SD. B-Type Natriuretic Peptide During Treatment with Sacubitril/Valsartan: The PARADIGM-HF Trial. Journal of the American College of Cardiology March 2019; 73(11): 1264-1272.
Packer M. What have we learned from randomized controlled trials of catheter ablation for atrial fibrillation in patients with chronic heart failure? Circulation: Arrhythmia and Electrophysiology April 2019; 12(4): e007222.
Packer M. Major reduction in the risk of sudden cardiac death in patients with chronic heart failure with the use of drug and device combinations that favorably affect left ventricular structure. European Journal of Heart Failure 2019; In Press.
Packer M. Is any patient with chronic heart failure receiving the right dose of the right beta-blocker in primary care? American Journal of Medicine 2019; In Press.
Packer M, Grayburn PA. Neurohormonal and Transcatheter Repair Strategies for Proportionate and Disproportionate Functional Mitral Regurgitation in Heart Failure. JACC: Heart Failure June 2019; 7(6): 518-521.
Packer M. Compelling First-Line Drug and Device Therapies for the Prevention of Sudden Death in Patients with Chronic Heart Failure and a Reduced Ejection Fraction Who Are Candidates for an Implantable Cardioverter-Defibrillator. Circulation Arrhythmia and Electrophysiology June 2019; 12(6): e007430.
Packer M. Critical Role of the Epicardium in Mediating Cardiac Inflammation and Fibrosis in Patients with Type 2 Diabetes. Diabetes, Obesity and Metabolism 2019; In Press.
Packer M. Disproportionate Functional Mitral Regurgitation: A New Therapeutic Target in Patients with Heart Failure and a Reduced Ejection Fraction. European Journal of Heart Failure 2019; In Press.
Packer M. Electrophysiological interventions in the treatment of chronic heart failure: a comparison of the strength of evidence supporting cardiac resynchronization for electrical conduction delay and catheter ablation for atrial fibrillation. European Heart Journal April 2019; 21(4): 398-401.
Packer M. When Cardiovascular Trials Collide. European Heart Journal February 2019; 40(6): 501-504.
Packer M, Grayburn PA. Contrasting Effects of Pharmacological, Procedural and Surgical Interventions on Proportionate and Disproportionate Functional Mitral Regurgitation in Chronic Heart Failure. Circulation May 2019; Epub.
Packer M. Is Long-Standing Atrial Fibrillation a Biomarker of or Contributor to the Symptoms or Progression of Chronic Heart Failure? The American Journal of Medicine June 2019; Epub.
Packer M. Are healthcare systems now ready to adopt sacubitril/valsartan as the preferred approach to inhibiting the renin-angiotensin system in chronic heart failure? The culmination of a 20-year journey. European Heart Journal May 2019; Epub.
Packer M. Effect of catheter ablation on pre-existing abnormalities of left atrial systolic, diastolic, and neurohormonal functions in patients with chronic heart failure and atrial fibrillation. European Heart Journal June 2019; 40(23): 1873-1879.
Packer M. The conundrum of patients with obesity, exercise intolerance, elevated ventricular filling pressures and a measured ejection fraction in the normal range. European Journal of Heart Failure Feb 2019; 21(2): 156-162.
Qamer SZ, Malik A, Bayoumi E, Lam PH, Singh S, Packer M, Kanonidis IE, Morgan CJ, Abdelmawqoud A, Allman RM, Fonarow GC, Ahmed A. Digoxin Use and Outcomes in Patients with Heart Failure with Reduced Ejection Fraction. The American Journal of Medicine May 2019; Epub.
Rangaswami J, Bhalla V, Blair JEA, Chang TI, Costa S, Lentine KL, Lerma EV, Mezue K Molitch M, Mullens W, Ronco C, Tang WHW, McCullough PA, American Heart Association Council on the Kidney in Cardiovascular Disease and Council on Clinical Cardiology. Cardiorenal Syndrome: Classification, Pathophysiology, Diagnosis, and Treatment Strategies: A Scientific Statement from the American Heart Association. Circulation March 2019; Epub
Rangaswami J, Soman S, McCullough PA. Key Updates in Cardio-Nephrology from 2018: Springboard to a Bright Future. Cardiorenal Medicine April 2019; 9(4): 222-228.
Rangaswami J, McCullough PA. Clinical Context of Dyskalemias Across the Heart Failure Spectrum and Their Associated Adverse Outcomes. JACC Heart Failure June 2019; 7(6): 533.
Rangaswami J, Mathew RO, Parasuraman R, Tantisattamo E, Lubetzky M, Rao S, Yaqub MS, Birdwell KA, Bennett W, Dala P, Kapoor R, Lerma EV, Lerman M, McCormick N, Bangalore S, McCullough PA, Dadhania DM. Cardiovascular Disease in the Kidney Transplant Recipient: Epidemiology, Diagnosis and Management Strategies. Nephrology, Dialysis, Transplantation: Official Publication of the European Dialysis and Transplant Association – European Renal Association May 2019; 34(5): 760-773.
Reardon MJ, Feldman TE, Meduri CU, Makkar RR, O’Hair D, Linke A, Kereiakes DJ, Waksman R, Babliaros V, Stoler RC, Mishkel GJ, Rizik DG, Iyer VS, Gleason TG, Tchetche D, Rovin JD, Lhermusier T, Carrie D, Hodson RW, Allocco DJ, Meredith IT. Two-Year Outcomes After Transcatheter Aortic Valve Replacement with Mechanical vs. Self-Expanding Valves: The REPRISW III Randomized Clinical Trial. JAMA Cardiology March 2019; 4(3): 223-229.
Rizk DV, Silva AL, Pergola PE, Toto R, Warnock DG, Chin MP, Goldsberry A, O’Grady M, Meyer CJ, McCullough PA. Effects of Bardoxolone Methyl on Magnesium in Patients with Type 2 Diabetes Mellitus and Chronic Kidney Disease. Cardiorenal Medicine June 2019; 1-10.
Roberts CS, Carry MM, Choi JW, Grayburn PA, Roberts WC. Papillary fibroelastoma in the left atrium. Baylor University Medical Proceedings April 2019; 32(2): 247-248.
Roberts WC. Hazards of Mitral Valve Replacement for Mitral Stenosis Caused by Massive Mitral Annular Calcium with or without Aortic Valve Replacement for Aortic Stenosis. American Journal of Cardiology Feb 2019; 123(4): 650-657.
Roberts WC, Grayburn PA, Lander SR, Meyer DM, Hall SA. Effect of Progressive Left Ventricular Dilation on Degree of Mitral Regurgitation Secondary to Mitral Valve Prolapse. American Journal of Cardiology Jun 2019; 123(11): 1887-1888.
Roberts WC. Proceedings of the Editorial Board Meeting of The American Journal of Cardiology on March 17, 2019, in New Orleans, Louisiana. American Journal of Cardiology July 2019; 124(1): 164-165.
Roberts WC, Haque S, Hall SA. Total 12-Lead QRS Voltage in Patients Having Orthotopic Heart Transplantation for Heart Failure Caused by Adriamycin-Induced Cardiomyopathy. Cardiology (Switzerland) Feb 2019; 141(3): 172-175.
Roberts WC. Facts and Ideas from Anywhere. Baylor University Medical Center Proceedings March 2019; 32(2): 314-321.
Roberts WC. From the Editor Pellagra, Osler, Roberts, Goldberger, the Atherosclerotic Diet, Niacin, the Beginning of the Atherosclerotic Epidemic, and the First Lipid-Altering Drug. The American Journal of Cardiology Feb 2019; 123(4): 697-700.
Rorth R, Jhund PS, Kristensen SL, Desai AS, Kober L, Rouleau JL, Solomon SD, Swedberg K, Zile MR, Packer M, McMurray JJV. The prognostic value of troponin T and N-terminal pro B-type natriuretic peptide, alone and in combination, in heart failure patients with and without diabetes. European Journal of Heart Failure Jan 2019; 21(1): 40-49.
Sannino A, Potluri S, Pollock B, Filardo G, Gopal A, Stoler RC, Szerlip M, Chowdhury A, Mack MJ, Grayburn PA. Impact of Mitral Stenosis on Survival in Patients Undergoing Isolated Transcatheter Aortic Valve Implantation. American Journal of Cardiology April 2019; 123(8): 1314-1320.
Soraija P, Moat N, Badhwar V, Walters D, Paone G, Bethea B, Bae R, Dahle G, Mumtaz M, Grayburn P, Kapadia S, Babaliaros V, Guerrero M, Satler L, Thourani V, Bedogni F, Rizik D, Denti P, Dumonteil N, Modine T, Sinhal A, Chuang ML, Pompa JJ, Blanke P, Leipsic J, Muller D. Initial Feasibility Study of a New Transcatheter Mitral Prosthesis: The First 100 Patients. Journal of the American College of Cardiology March 2019; 73(11): 1250-1260.
Spinowitz BS, Fishbane S, Pergola PE, Roger SD, Lerma SD, Butler J, von Haehling S, Adler SH, Zhao J, Singh B, Lavin PT, McCullough PA, Kosiborod M, Packman DK, ZS-005 Study Investigators. Sodium Zirconium Cyclosillcate among Individuals with Hyperkalemia: A 12-Month Phase 3 Study. Clinical Journal of American Society of Nephrology June 2019; 14(6): 798-809.
Sudhakaran S, McCullough PA. Common laboratory parameters as indicators of multi-organ dysfunction in acute heart failure. European Journal of Heart Failure June 2019; 21(6): 751-753.
Tajti P, Alaswad K, Karmpaliotis D, Jaffer FA, Yeh RW, Patel M, Mahmud E, Choi JW, Burke MN, Doing AH, Dattilo P, Toma C, Smith AJC, Uretsky BF, Holper E, Potluri S, Wyman RM, Kandzari DE, Garcia S, Krestyaninov O, Khelimskii D, Koutouzis M, Tsiafoutis I, Khatri JJ, Jaber W, Samady H, Jefferson B, Patel T, Abdullah S, Moses JW, Lembo NJ, Parikh M, Kirtane AJ, Ali ZA, Doshi D, Xenogiannis I, Stanberry LI, Rangan BV, Ungi I, Banerjee S, Brilakis ES. Procedural Outcomes of Percutaneous Coronary Interventions for Chronic Total Occlusions Via the Radial Approach: Insights from an International Chronic Total Occlusion Registry. JACC Cardiovascular Interventions Feb 2019; 12(4): 346-358.
Tajti P, Karmpaliotis D, Alaswad K, Jaffer FA, Yeh RW, Patel M, Mahumd E, Choi JW, Burke MN, Doing AH, Dattilo P, Toma C, Smith AJC, Uretsky B, Holper E, Potluri S, Wyman RM, Kandzari DE, Garcia S, Krestyaninov O, Khelimskii D, Koutouzis M, Tsiafoutis I, Jaber W, Samady H, Moses JW, Lembo NJ, Parikh M, Kirtane AJ, Ali ZA, Doshi D, Xenogiannis I, Stanberry LI, Rangan BV, Ungi I, Banerjee S, Brilakis ES. In-Hospital Outcomes of Chronic Total Occlusion Percutaneous Coronary Interventions in Patients with Prior Coronary Artery Bypass Graft Surgery. Circulation. Cardiovascular Interventions March 2019; 12(3): e007338.
Tecson KM, Hashemi H, Afzal A, Gong TA, Kale P, McCullough PA. Community-Acquired Acute Kidney Injury as a Risk Factor of de novo Heart Failure Hospitalization. CardioRenal Medicine May 2019; 9(4): 252-260.
Vardeny O, Claggett B, Kachadourian J, Desai AS, Packer M, Rouleau J, Zile MR, Lefkowitz M, Shi V, McMurray JJV, Solomon SD. Reduced loop diuretic use in patients taking sacubitril/valsartan compared with enalapril: the PARADIGM-HF trial. European Journal of Heart Failure March 2019; 21(3): 337-341.
Vasudevan A, Choi JW, Feghali GA, Lander SR, Jialiang L, Schussler JM, Stoler RC, Vallabhan RC, Velasco CE, McCullough PA. Event dependence in the analysis of cardiovascular readmissions postpercutaneous coronary intervention. Journal of Investigational Medicine Jan 2019; 0: 1-7.
Vijayaraghaven K, McCullough PA, Singh B, Gupta M, Enas E, Mohan V, Misra A, Deedwania P, Brinton EA. Cardiometabolic-Renal Disease in South Asians: Consensus Recommendations from the Cardio Renal Society of America. CardioRenal Medicine 2019; 9: 240-251.
Xenogiannis I, Karmpaliotis D, Alaswad K, Jaffer FA, Yeh RW, Patel M, Mahmud E, Choi JW, Burke MN, Doing AH, Dattilo P, Toma C, Smith AJC, Uretsky B, Krestyaninov O, Khelimskii D, Holper E, Potluri S, Wyman RM, Kandzari DE, Garcia S, Koutouzis M, Tsiafoutis I, Khatri JJ, Jaber W, Samdy H, Jefferson BK, Patel T, Moses JW, Lembo NJ, Parikh M, Kirtane AJ, Ali ZA, Doshi D, Tajti P, Rangan BV, Abdullah S, Banerjee S, Drilakis ES. Usefulness of Atherectomy in Chronic Total Occlusion Interventions (from the PROGRESS-CTO Registry). American Journal of Cardiology May 2019; 123(9): 1422-1428.
Xenogiannis I, Karmpaliotis D, Alaswad K, Basir MB, Yeh RW, Tamez H, Patel M, Mahmud E, Choi JW, Burke MN, Doing AH, Dattilo P, Khatri JJ, Sheikh AM, Malik BA, Greene ME, Abi Rafeh N, Maalou A, Abou Jaoudeh F, Moses JW, Lembo NJ, Parikh M, Kirtane AJ, Ali ZA, Gkargkoulas F, Russo J, Hakemi E, Tajti P, Hall AB, Vemmou E, Nikolakopoulos I, Rangan BV, Abdullah S, Banerjee S, Brilakis ES. Left Main Chronic Total Occlusion Percutaneous Coronary Intervention: A Case Series. The Journal of Invasive Cardiology July 2019; 31(7): E220-E225.
Zanoli L, Lentini P, Briet M, Castellino P, House AA, London GM, Malatino L, McCullough PA, Mikhailidis DP, Boutouyrie P. Aterial Stiffness in the Heart Disease of CKD. Journal of the American Society of Nephrology: JASN Jun 2019; 30(6): 918-928.
Zile MR, O’Meara E, Claggett B, Prescott MF, Solomon SD, Swedberg K, Packer M, McMurray JJV, Shi V, Lefowitz M, Rouleau J. Effects of Sacubitril/Valsartan on Biomarkers of Extracellular Matrix Regulation in Patients with HfrEF. Journal of the American College of Cardiology Feb 2019; 73(7): 795-806.
Zoghbi WA, Asch FM, Bruce C, Gillam LD, Grayburn PA, Hahn RT, Inglessis I, Islam AM, Lerakis S, Little SH, Siegel RJ, Skubas N, Slesnick TC, Stewart WJ, Thavendiranathan P, Weissman NJ, Yasukochi S, Zimmerman KG. Guidelines for the Evaluation of Valvular Regurgitation After Percutaneous Valve Repair or Replacement: A Report from the American Society of Echocardiography Developed in Collaboration with the Society for Cardiovascular Angiography and Interventions, Japanese Society of Echocardiography and Society for Cardiovascular Magnetic Resonance. Journal of the American Society of Echocardiography April 2019; 32(4): 431-475.
Roberts WC, Lee AY, Lander SR, Roberts CS, Hamman BL. Libman-Sacks Endocarditis Involving a Bioprosthesis in the Aortic Valve Position in Systemic Lupus Erythematosus. American Journal of Cardiology July 2019; 124(2): 316-318.
Roberts WC. Proceedings of the Editorial Board Meeting of The American Journal of Cardiology on March 17, 2019, in New Orleans, Louisiana. American Journal of Cardiology July 2019; 124(1): 164-165.
Roberts WC. Facts and Ideas from Anywhere. Baylor University Medical Center Proceedings March 2019; 32(2): 314-321.
Roberts WC. From the Editor Pellagra, Osler, Roberts, Goldberger, the Atherosclerotic Diet, Niacin, the Beginning of the Atherosclerotic Epidemic, and the First Lipid-Altering Drug. The American Journal of Cardiology Feb 2019; 123(4): 697-700.
Rorth R, Jhund PS, Kristensen SL, Desai AS, Kober L, Rouleau JL, Solomon SD, Swedberg K, Zile MR, Packer M, McMurray JJV. The prognostic value of troponin T and N-terminal pro B-type natriuretic peptide, alone and in combination, in heart failure patients with and without diabetes. European Journal of Heart Failure Jan 2019; 21(1): 40-49.
Selvaraj S, Claggett B, Pozzi A, McMurray JJV, Jhund PS, Packer M, Desai AS, Lewis EF, Vaduganathan M, Lefkowitz MP, Rouleau JL, Shi VC, Zile MR, Swedberg K, Solomon SD. Prognostic Implications of Congestion on Physical Examination Among Contemporary Patients with Heart Failure and Reduced Ejection Fraction: PARADIGM-HF. Circulation Oct 2019; 140(17): 1369-1379.
Shahian DM, Gleason TG, Shemin RJ, Carroll JD, Mack MJ. TAVR 2.0: Professional Societies Collaborating to Measure, Assure, and Improve Quality. Annals of Thoracic Surgery Feb 2019; 107(2): 329-330.
Singhania G, Ejaz AA, McCullough PA, Kluger AY, Balamuthusamy S, Dass B, Singhania N, Agarwal A. Continuation of Chronic Heart Failure Therapies During Heart Failure Hospitalization – a Review. Reviews in Cardiovascular Medicine Sept 2019; 3(30): 111-120.
Solomon SD, McMurray JJV, Anand IS, Ge J, Lam CSP, Maggioni AP, Martinez F, Packer M, Pfeffer MA, Pieske B, Redfield MM, Rouleau JL, Van Veldhuisen DJ, Zannad F, Zile MR, Desai AS, Clagget B, Jhund PS, Boytsov SA, Comin-Colet J, Cleland J, Dungen HD, Goncalvesova E, Katova T, Kerr Saraiva JF, Lelonek M, Merkley B, Senni M, Shah SJ, Zhou J, Rizkala AR, Gong J, Shi VC, Lefkowitz MP. Angiotensin-neprilysin inhibition in heart failure with preserved ejection fraction. New England Journal of Medicine Oct 2019; 381(17): 1609-1620.
Soraija P, Moat N, Badhwar V, Walters D, Paone G, Bethea B, Bae R, Dahle G, Mumtaz M, Grayburn P, Kapadia S, Babaliaros V, Guerrero M, Satler L, Thourani V, Bedogni F, Rizik D, Denti P, Dumonteil N, Modine T, Sinhal A, Chuang ML, Pompa JJ, Blanke P, Leipsic J, Muller D. Initial Feasibility Study of a New Transcatheter Mitral Prosthesis: The First 100 Patients. Journal of the American College of Cardiology March 2019; 73(11): 1250-1260.
Spinowitz BS, Fishbane S, Pergola PE, Roger SD, Lerma SD, Butler J, von Haehling S, Adler SH, Zhao J, Singh B, Lavin PT, McCullough PA, Kosiborod M, Packman DK, ZS-005 Study Investigators. Sodium Zirconium Cyclosillcate among Individuals with Hyperkalemia: A 12-Month Phase 3 Study. Clinical Journal of American Society of Nephrology June 2019; 14(6): 798-809.
Starr P, Agarwal A, Singh G, Hsu E, Zhang W, Kuo YF, Boethel C, Sharma G. Obstructive Sleep Apnea with Chronic Obstructive Pulmonary Disease Among Medicare Beneficiaries. Annals of the American Thoracic Society Jan 2019; 16(1): 153-156.
Sudhakaran S, McCullough PA. Common laboratory parameters as indicators of multi-organ dysfunction in acute heart failure. European Journal of Heart Failure June 2019; 21(6): 751-753.
Tajti P, Alaswad K, Karmpaliotis D, Jaffer FA, Yeh RW, Patel M, Mahmud E, Choi JW, Burke MN, Doing AH, Dattilo P, Toma C, Smith AJC, Uretsky BF, Holper E, Potluri S, Wyman RM, Kandzari DE, Garcia S, Krestyaninov O, Khelimskii D, Koutouzis M, Tsiafoutis I, Khatri JJ, Jaber W, Samady H, Jefferson B, Patel T, Abdullah S, Moses JW, Lembo NJ, Parikh M, Kirtane AJ, Ali ZA, Doshi D, Xenogiannis I, Stanberry LI, Rangan BV, Ungi I, Banerjee S, Brilakis ES. Procedural Outcomes of Percutaneous Coronary Interventions for Chronic Total Occlusions Via the Radial Approach: Insights from an International Chronic Total Occlusion Registry. JACC Cardiovascular Interventions Feb 2019; 12(4): 346-358.
Tecson KM, Hashemi H, Afzal A, Gong TA, Kale P, McCullough PA. Community-Acquired Acute Kidney Injury as a Risk Factor of de novo Heart Failure Hospitalization. CardioRenal Medicine May 2019; 9(4): 252-260.
Thakkar SJ, Grayburn PA, Hall SA, Roberts WC. Orthotopic Heart Transplantation for Ankylosing Spondylitis Masquerading as Nonischemic Cardiomyopathy. American Journal of Cardiology May 2019; 123(10): 1732-1735.
Vardeny O, Claggett B, Kachadourian J, Desai AS, Packer M, Rouleau J, Zile MR, Lefkowitz M, Shi V, McMurray JJV, Solomon SD. Reduced loop diuretic use in patients taking sacubitril/valsartan compared with enalapril: the PARADIGM-HF trial. European Journal of Heart Failure March 2019; 21(3): 337-341.
Vasudevan A, Choi JW, Feghali GA, Lander SR, Jialiang L, Schussler JM, Stoler RC, Vallabhan RC, Velasco CE, McCullough PA. Event dependence in the analysis of cardiovascular readmissions postpercutaneous coronary intervention. Journal of Investigational Medicine Jan 2019; 0: 1-7.
Vasudevan A, Choi JW, Feghali GA, Kluger AY, Lander SR, Tecson KM, Sathyamoorthy M, Schussler JM, Stoler RC, Vallabhan RC, Velasco CE, Yoon A, McCullough PA. First and recurrent events after percutaneous coronary intervention: implications for survival analyses. Scandinavian Cardiovascular Journal 2019; Epub.
Vijayaraghaven K, McCullough PA, Singh B, Gupta M, Enas E, Mohan V, Misra A, Deedwania P, Brinton EA. Cardiometabolic-Renal Disease in South Asians: Consensus Recommendations from the Cardio Renal Society of America. CardioRenal Medicine 2019; 9: 240-251.
Wilson DP, Jacobson TA, Jones PH, Koschinsky ML, McNeal CJ, Nordestgaard BG, Orringer CE. Use of lipoprotein (a) in clinical practice: A biomarker whose time has come. A scientific statement from the National Lipid Association. Don P. Wilson, MD, on behalf of the Writing group. Journal of Clinical Lipidology May 2019; Epub.
Xenogiannis I, Karmpaliotis D, Alaswad K, Jaffer FA, Yeh RW, Patel M, Mahmud E, Choi JW, Burke MN, Doing AH, Dattilo P, Toma C, Smith AJC, Uretsky B, Krestyaninov O, Khelimskii D, Holper E, Potluri S, Wyman RM, Kandzari DE, Garcia S, Koutouzis M, Tsiafoutis I, Khatri JJ, Jaber W, Samdy H, Jefferson BK, Patel T, Moses JW, Lembo NJ, Parikh M, Kirtane AJ, Ali ZA, Doshi D, Tajti P, Rangan BV, Abdullah S, Banerjee S, Drilakis ES. Usefulness of Atherectomy in Chronic Total Occlusion Interventions (from the PROGRESS-CTO Registry). American Journal of Cardiology May 2019; 123(9): 1422-1428.
Xenogiannis I, Karmpaliotis D, Alaswad K, Basir MB, Yeh RW, Tamez H, Patel M, Mahmud E, Choi JW, Burke MN, Doing AH, Dattilo P, Khatri JJ, Sheikh AM, Malik BA, Greene ME, Abi Rafeh N, Maalou A, Abou Jaoudeh F, Moses JW, Lembo NJ, Parikh M, Kirtane AJ, Ali ZA, Gkargkoulas F, Russo J, Hakemi E, Tajti P, Hall AB, Vemmou E, Nikolakopoulos I, Rangan BV, Abdullah S, Banerjee S, Brilakis ES. Left Main Chronic Total Occlusion Percutaneous Coronary Intervention: A Case Series. The Journal of Invasive Cardiology July 2019; 31(7): E220-E225.
Yarlagadda B, Deneke T, Turagam M, Dar T, Paleti S, Parikh V, DiBiase L, Halfbass P, Santangeli P, Mahapatra S, Cheng J, Russo A, Edgerton J, Mansour M, Ruskin J, Dukkipati S, Wilber D, Reddy V, Packer D, Natale A, Lakkireddy D. Temporal Relationships Between Esophageal Injury Type and Progression in Patients Undergoing Atrial Fibrillation Catheter Ablation. Heart Rhythm Feb 2019; 16(2): 204-212.
Zanoli L, Lentini P, Briet M, Castellino P, House AA, London GM, Malatino L, McCullough PA, Mikhailidis DP, Boutouyrie P. Aterial Stiffness in the Heart Disease of CKD. Journal of the American Society of Nephrology: JASN Jun 2019; 30(6): 918-928.
Zile MR, O’Meara E, Claggett B, Prescott MF, Solomon SD, Swedberg K, Packer M, McMurray JJV, Shi V, Lefowitz M, Rouleau J. Effects of Sacubitril/Valsartan on Biomarkers of Extracellular Matrix Regulation in Patients with HfrEF. Journal of the American College of Cardiology Feb 2019; 73(7): 795-806.
McCullough PA, Ostermann M, Forni LG, Bihorac A, Koyner JL, Chawla LS, Shi J, Kampf JP, McPherson P, Kellum JA; the Sapphire Investigators. Serial Urinary Tissue Inhibitor of Metalloproteinase-2 and Insulin-Like Growth Factor-Binding Protein 7 and the Prognosis for Acute Kidney Injury over the Course of Critical Illness. Cardiorenal Med. 2019;9(6):358-369. doi: 10.1159/000502837. Epub 2019 Oct 16.
Butler, J.a, Packer, M., Greene, S.J.c, Fiuzat, M.c, Anker, S.D.d,e, Anstrom, K.J.c, Carson, P.E.f,g, Cooper, L.B.h, Fonarow, G.C.i, Hernandez, A.F.c, Januzzi, J.L.j, Jessup, M.k, Kalyani, R.R.l, Kaul, S.m, Kosiborod, M.n,o, Lindenfeld, J.p, McGuire, D.K.q, Sabatine, M.S.r, Solomon, S.D.s, Teerlink, J.R.t,u, Heart Failure End Points in Cardiovascular Outcome Trials of Sodium Glucose Cotransporter 2 Inhibitors in Patients with Type 2 Diabetes Mellitus: A Critical Evaluation of Clinical and Regulatory Issues. Circulation: Volume 140, Issue 25, 17 December 2019, Pages 2108-2118
Balceniuk, M.D., Hosn, M.A., Corn, R.S., DerDerian, T., Grimsley, B.R.c, Long, P., Moore, W.S., Rossi, P.J., Shakir, H.J., Siddiqui, A.H., Spadone, D.P., Waqas, M., Stoner, M.C. Endovascular stenting of supra-aortic lesions using a transcarotid retrograde approach and flow reversal: A multicenter case series. Journal of Vascular Surgery 2019
Raju B1, McCullough PA. eCollection 2019 Nov. Unraveling the Molecular Mechanism of Action of Empagliflozin in Heart Failure With Reduced Ejection Fraction With or Without Diabetes. JACC Basic Transl Sci. 2019 Oct 23;4(7):831-840. doi: 10.1016/j.jacbts.2019.07.010.
Iborra-Egea O1,2,3, Santiago-Vacas E1,2,3, Yurista SR4, Lupón J1,2,3, Packer M5, Heymans S6, Zannad F7, Butler J8, Pascual-Figal D9, Lax A9, Núñez J10, de Boer RA4, Bayés-Genís A1,2,3. Circulating plasma dipeptidyl dipeptidase 3 and the prognosis of cardiogenic shock. Eur J Heart Fail. 2020 Feb;22(2):287-289. doi: 10.1002/ejhf.1623. Epub 2019 Nov 28.
Lo KB, Gul F, Ram P, Kluger AY, Tecson KM, McCullough P, Rangaswami J. The Effects of SGLT2 Inhibitors on Cardiovascular and Renal Outcomes in Diabetic Patients: A Systematic Review and Meta-Analysis. Cardiorenal Med. 2020;10(1):1-10. doi: 10.1159/000503919. Epub 2019 Nov 19.
Hahn RT, Mahmood F, Kodali S, Lang R, Monaghan M, Gillam LD, Swaminathan M, Bonow RO, von Bardeleben RS, Bax JJ, Grayburn P, Zoghbi WA, Sengupta PP, Chandrashekhar Y, Little SH. Core Competencies in Echocardiography for Imaging Structural Heart Disease Interventions: An Expert Consensus Statement. JACC Cardiovasc Imaging. 2019 Dec;12(12):2560-2570. doi: 10.1016/j.jcmg.2019.10.008.
Packer M - Risks of Intensive Treatment of Long-Standing Atrial Fibrillation in Patients With Chronic Heart Failure With a Reduced or Preserved Ejection Fraction. Circ Cardiovasc Qual Outcomes. 2019 Aug;12(8):e005747. doi: 10.1161/CIRCOUTCOMES.119.005747. Epub 2019 Jul 25.
Packer M - Nonarrhythmic Sudden Cardiac Death in Chronic Heart Failure-A Preventable Event? - PMID: 31314058 DOI: 10.1001/jamacardio.2019.2228
Hamandi, Mohanad; Ryan, William H; Grayburn, Paul A; Huff, Eleanor; Mallari, Laila; Mack, Michael J. Misclassification of Mitral Valve Disease and Rate of Surgical Repair in The Society of Thoracic Surgeons Database. The annals of thoracic surgery. ISSN: 0003-4975, 1552-6259; DOI: 10.1016/j.athoracsur.2019.11.047. ,2020
Puri V, Gaissert HA, Wormuth DW, Grogan EL, Burfeind WR, Chang AC, Seder CW, Fernandez FG, Brown L, Magee MJ, Kosinski AS, Raymond DP, Broderick SR, Welsh RJ, DeCamp MM, Farjah F, Edwards MA, Kozower BD. Defining Proficiency for The Society of Thoracic Surgeons Participants Performing Thoracoscopic Lobectomy. Annals of Thoracic Surgery Jan 2019; 107(1): 202-208.
Rizk DV, Silva AL, Pergola PE, Toto R, Warnock DG, Chin MP, Goldsberry A, O’Grady M, Meyer CJ, McCullough PA. Effects of Bardoxolone Methyl on Magnesium in Patients with Type 2 Diabetes Mellitus and Chronic Kidney Disease. Cardiorenal Medicine June 2019; 1-10.
Elbadawi A, Elgendy IY, Mahmoud K, Barakat AF, Mentias A, Mohamed AH, Ogunbayo GO, Megaly M, Saad M, Omer MA, Paniagua D, Abbott JD, Jneid H - Temporal Trends and Outcomes of Mechanical Complications in Patients With Acute Myocardial Infarction.. JACC Cardiovasc Interv. 2019 Sep 23;12(18):1825-1836. doi: 10.1016/j.jcin.2019.04.039.
Raju, B.a, McCullough, P.A. Circulating plasma dipeptidyl dipeptidase 3 and the prognosis of cardiogenic shock. European Journal of Heart Failure 2019: IN PRESS
Orimoloye OA, Kambampati S, Hicks AJ, III, Rifai MA, Silverman MG, Whelton S, Qureshi W, Ehrman JK, Keteyian SJ, Brawner CA, Dardari Z, Al-Mallah MH, Blaha MJ. Higher cardiorespiratory fitness predicts long-term survival in patients with heart failure and preserved ejection fraction: The Henry Ford exercise Testing (FIT) project. Archives of Medical Science March 2019; 15(2): 350-358.
Packer M. What have we learned from randomized controlled trials of catheter ablation for atrial fibrillation in patients with chronic heart failure? Circulation: Arrhythmia and Electrophysiology April 2019; 12(4): e007222.
Packer M. Major reduction in the risk of sudden cardiac death in patients with chronic heart failure with the use of drug and device combinations that favorably affect left ventricular structure. European Journal of Heart Failure 2019; Eur J Heart Fail. 2019 Jul;21(7):823-826. doi: 10.1002/ejhf.1501. Epub 2019 May 29.
Packer M. Is any patient with chronic heart failure receiving the right dose of the right beta-blocker in primary care? American Journal of Medicine 2019; Am J Med. 2019 Nov;132(11):e761-e762. doi: 10.1016/j.amjmed.2019.03.026. Epub 2019 Apr 12.
Packer M, Grayburn PA. Neurohormonal and Transcatheter Repair Strategies for Proportionate and Disproportionate Functional Mitral Regurgitation in Heart Failure. JACC: Heart Failure June 2019; 7(6): 518-521.
Packer M. Compelling First-Line Drug and Device Therapies for the Prevention of Sudden Death in Patients with Chronic Heart Failure and a Reduced Ejection Fraction Who Are Candidates for an Implantable Cardioverter-Defibrillator. Circulation Arrhythmia and Electrophysiology June 2019; 12(6): e007430.
Packer M. Critical Role of the Epicardium in Mediating Cardiac Inflammation and Fibrosis in Patients with Type 2 Diabetes. Diabetes, Obesity and Metabolism 2019; Diabetes Obes Metab. 2019 Aug;21(8):1765-1768. doi: 10.1111/dom.13792. Epub 2019 Jun 17.
Packer M. Disproportionate Functional Mitral Regurgitation: A New Therapeutic Target in Patients with Heart Failure and a Reduced Ejection Fraction. European Journal of Heart Failure 2019; Eur J Heart Fail. 2020 Jan;22(1):23-25. doi: 10.1002/ejhf.1469. Epub 2019 Apr 24.
Packer M. Electrophysiological interventions in the treatment of chronic heart failure: a comparison of the strength of evidence supporting cardiac resynchronization for electrical conduction delay and catheter ablation for atrial fibrillation. European Heart Journal April 2019; 21(4): 398-401.
Packer M. When Cardiovascular Trials Collide. European Heart Journal February 2019; 40(6): 501-504.
Packer M, Grayburn PA. Contrasting Effects of Pharmacological, Procedural and Surgical Interventions on Proportionate and Disproportionate Functional Mitral Regurgitation in Chronic Heart Failure. Circulation May 2019; Epub.
Packer M. Is Long-Standing Atrial Fibrillation a Biomarker of or Contributor to the Symptoms or Progression of Chronic Heart Failure? The American Journal of Medicine June 2019; Epub.
Packer M. Are healthcare systems now ready to adopt sacubitril/valsartan as the preferred approach to inhibiting the renin-angiotensin system in chronic heart failure? The culmination of a 20-year journey. European Heart Journal May 2019; Epub.
Packer M. Effect of catheter ablation on pre-existing abnormalities of left atrial systolic, diastolic, and neurohormonal functions in patients with chronic heart failure and atrial fibrillation. European Heart Journal June 2019; 40(23): 1873-1879.
Packer M. The conundrum of patients with obesity, exercise intolerance, elevated ventricular filling pressures and a measured ejection fraction in the normal range. European Journal of Heart Failure Feb 2019; 21(2): 156-162.
Packer M. Disease-treatment interactions in the management of patients with obesity and diabetes who have atrial fibrillation: The potential mediating influence and epicardial adipose tissue. Cardiovascular Diabetology September 2019; 18(1): 121.
Packer M, Butler J, Filippatos GS, Jamal W, Salsali A, Schnee J, Kimura K, Zeller C, George J, Brueckmann M, Anker SD, Zannad F, EMPEROR-Reduced Trial Committees and Investigators. Evaluation of the effect of sodium-glucose co-transporter 2 inhibition with empagliflozin on morbidity and mortality of patients with chronic heart failure and a reduced ejection fraction: rationale for an design of the EMPEROR-Reduced trial. European Journal of Heart Failure October 2019; 21(10): 1270-1278.
Packer M. Reconceptualization of the molecular mechanism by which sodium-glucose cotransporter 2 inhibitors reduce the risk of heart failure events. Circulation Aug 2019; 140(6): 443-445.
Packer M. Neurohormonal antagonists are preferred to an implantable cardioverter-defibrillator in preventing sudden death in heart failure. JACC: Heart Failure Oct 2019; 7(10): 902-906.
Packer M. Methodological and Clinical Heterogeneity and Extraction Errors in Meta-Analyses of Catheter Ablation for Atrial Fibrillation in Heart Failure. Journal of the American Heart Association Nov 2019; 8(21): e013779.
Packer M. Drugs that ameliorate epicardial adipose tissue inflammation may have discordant effects in heart failure with a preserved ejection fraction as compared with a reduced ejection fraction. Journal of Cardiac Failure J Card Fail. 2019 Dec;25(12):986-1003. doi: 10.1016/j.cardfail.2019.09.002. Epub 2019 Sep 18.
Packer M. Lessons learned from the DAPA-HF trial concerning the mechanisms of benefit of SGLT2 inhibitors on heart failure events in the context of other large-scale trials nearing completion. Cardiovascular Diabetology Oct 2019; 18(1): 129.
Parwani P, Choi AD, Lopez-Mattei J, Raza S, Chen T, Narang A, Michos ED, Erwin JP III, Mamas MA, Gulati M. Understanding Social Media: Opportunities for Cardiovascular Medicine. Journal of the American College of Cardiology March 2019; 73(9): 1089-1093.
Qamer SZ, Malik A, Bayoumi E, Lam PH, Singh S, Packer M, Kanonidis IE, Morgan CJ, Abdelmawqoud A, Allman RM, Fonarow GC, Ahmed A. Digoxin Use and Outcomes in Patients with Heart Failure with Reduced Ejection Fraction. The American Journal of Medicine May 2019; Epub.
Rangaswami J, Bhalla V, Blair JEA, Chang TI, Costa S, Lentine KL, Lerma EV, Mezue K Molitch M, Mullens W, Ronco C, Tang WHW, McCullough PA, American Heart Association Council on the Kidney in Cardiovascular Disease and Council on Clinical Cardiology. Cardiorenal Syndrome: Classification, Pathophysiology, Diagnosis, and Treatment Strategies: A Scientific Statement from the American Heart Association. Circulation March 2019; Epub.
Rangaswami J, Soman S, McCullough PA. Key Updates in Cardio-Nephrology from 2018: Springboard to a Bright Future. Cardiorenal Medicine April 2019; 9(4): 222-228.
Rangaswami J, McCullough PA. Clinical Context of Dyskalemias Across the Heart Failure Spectrum and Their Associated Adverse Outcomes. JACC Heart Failure June 2019; 7(6): 533.
Rangaswami J, Bangalore S, Kaplan B, Birdwell KA, Wiseman AC, McCullough PA, Dadhania DM. Cardiovascular disease care fragmentation in kidney transplantation: a call for action. Kidney International Sept 2019; 96(3): 568-571.
Anker SD, Butler J, Filippatos GS, Jamal W, Salsali A, Schnee J, Kimura K, Zeller C, George J, Brueckmann M, Zannad F, Packer M, Perrone S, Nicholls S, Janssens S, Bocchi E, Giannetti N, Verma S, Jian Z, Gomez Mesa JE, Spinar J, Bohm M, Merkley B, Chopra V, Senni M, Taddi S, Tsutsui H, Chuquiure E, La Rocca HPB, Ponikowski P, Vinereanu D, Sim D, Choi DJ, Juanatey JRG, Squire, I., Butler, J., Januzzi, J., Pina, I., Pocock, S.J., Carson, P., Doehner, W., Miller, A., Haas, M., Pehrson, S., Komajda, M., Anand, I., Teerlink, J., Rabinstein, A., Steiner, T., Kamel, H., Tsivgoulis, G., Lewis, J., Freston, J., Kaplowitz, N., Mann, J., Petrie, M., Bernstein, R., Cheung, A., Green, J., Januzzi, J., Kaul, S., Ping, C.L.S., Lip, G., Marx, N., McCullough, P., Mehta, C., Ponikowski, P., Rosenstock, J., Sattar, N., Scirica, B., Tsutsui, H., Verma, S., Wanner, C., Welty, F.K., Parhofer, K.G., Clayton, T., Pedersen, T.R., Lees, K.R., Konstam, M.A., Greenberg, B., Palmer, M., on behalf of the EMPEROR-Preserved Trial Committees and Investigators. Evaluation of the effects of sodium-glucose co-transporter 2 inhibition with empagliflozin on morbidity and mortality in patients with chronic heart failure and preserved ejection fraction: rationale for and redesign of the EMPEROR-Preserved Trial. European Heart Journal Oct 2019; 21(10): 1279-1287.
Butler J, Anker SD, Packer M. Redefining heart failure with reduced ejection fraction. Journal of American Medical Association Sept 2019; Epub.
Chandra A, Vaduganathan M, Lewis EF, Claggett BL, Rizkala AR, Wang W, Lefkowitz MP, Shi VC, Anand IS, GE J, Lam CSP, Maggioni AP, Martinez F, Packer M, Pfeffer MA, Redfield MM, Rouleau JL, Van Veldhusien DJ, Zannad F, Zile MR, McMurray JJV, Solomon SD, Paragon-HF Investigators. Health-related quality of life in heart failure with preserved ejection fraction: The PARAGON-HF Trial. JACC: Heart Failure Oct 2019; 7(10): 862-874.
Grayburn PA. Functional Mitral Valve Regurgitation. Current Cardiovascular Risk Reports October 2019; 13(10): 31.
Haq A, McCullough PA. The Promise of next generation sequencing micro RNA for the discovery of new targets in contrast induced acute kidney injury. Annals of Translational Medicine Sep 2019; 7(18): 424.
Husain-Syed F, Birk HW, Ronco C, Schormann T, Tello K, Richter MJ, Wilhelm J, Sommer N, Steyerberg E, Bauer P, Walmrath HD, Seeger W, McCullough PA, Gall H, Ghofrani HA. Doppler-Derived Renal Venous Stasis Index in the Prognosis of Right Heart Failure. Journal of the American Heart Association Nov 2019; 8(21): e013584.
Husain-Syed F, Birk HW, Tello K, Richter MJ, Ronco C, McCullough PA, Schomann T, Ferrari F, Yucel G, Yazdani B, Walmrath HD, Seeger W, Gail H, Ghofrani HA. Alterations in Doppler-derived renal venous stasis index during recompensation of right heart failure and fluid overload in a patient with pulmonary hypertension. Reviews in Cardiovascular Medicine Dec 2019; 20(4): 263-266.
Kluger AY, Tecson KM, Lerma EV, Rangaswami J, Lepor NE, Cobble ME, McCullough PA. Class Effects of SGLT2 Inhibitors on Cardiorenal Outcomes. Cardiovascular Diabetology Aug 2019; 18(1): 99.
Kotecha D, Gill SK, Flather MD, Holmes J, Packer M, Rosano G, Bohm M, McMurray JJV, Wikstrand J, Anker SD, van Veldhuisen DJ, Manzano L, von Lueder TG, Rigby AS, Anderrsson B, Kjekshus J, Wedel H, Ruschitzka F, Cleland JGF, Damman K, Redon J, Coats AJS. Beta-Blockers in Heart Failure Collaborative Group. Impact of Renal Impairment on Beta-Blocker Efficacy in Patients with Heart Failure. Journal of American College of Cardiology Dec 2019; 74(23): 2893-2904.
Malik A, Masson R, Singh S, Wu WC, Packer M, Pitt B, Waagstein F, Morgan CJ, Allman RM, Fonarow, GC, Ahmed A. Digoxin Discontinuation and Outcomes in Patients with Heart Failure with Reduced Ejection Fraction. Journal of the American College of Cardiology Aug 2019; 74(5): 617-627.
McCullough PA, Mehta HS, Barker CM, Cork DP, Gunnarsson C, Ryan MP, Baker ER, Van Houten J, Mollenkopf S, Verta P. The Economic Impact of Mitral Regurgitation on Patients with Medically Managed Heart Failure. American Journal of Cardiology Oct 2019; 124(8): 1226-1231.
Meduri CU, Kereiakes DJ, Rajagopal V, Makkar RR, O’Hair D, Linke A, Waksman R, Babliaros V, Stoler RC, Mishkel GJ, Rizik DG, Iyer VS, Schindler J, Allocco DJ, Meredith IT, Feldman TE, Reardon MJ. Pacemaker Implantation and Dependency after Transcatheter Aortic Valve Replacement in the REPRISE III Trial. Journal of the American Heart Association Nov 2019; 8(21): e012594.
Packer M. Why are physicians so confused about acute heart failure? New England Journal of Medicine Aug 2019; 381(8): 776-777.
Packer M. Heightened risk of intensive rate control in patients with atrial fibrillation who are obese or have type 2 diabetes: A critical review and re-evaluation. Journal of Cardiovascular Electrophysiology Dec 2019; 30(12): 3020-3024.
Packer M. The Parable of Schrodinger’s Cat and the Illusion of Statistical Significance in Clinical Trials. Circulation Sep 2019; 140(10): 799-800.
Rossing P, Block GA, Chin MP, Goldsberry A, Heerspink HJL, McCullough PA, Meyer CJ, Packham D, Pergola PE, Spinowitz B, Sprague SM, Warnock DG, Chertwo GM. Effect of bardoxolone methyl on the urine albumin-to-creatinine ratio in patients with type 2 diabetes and stage 4 chronic kidney disease. Kidney International Oct 2019; 96(4): 1030-1036.
Xu MX – Teng RL, Rudy TD, Schoenhagen P, Bartel T, Di Bartolomeo R, Aksoy O, Desai M, von Kodolitsch Y, Escaned J, McCullough PA, Vasudevan A, Shen CX, Zhao X, Zhou YF, Xu HF, Cheng XJ, He YM. The CatLet score: a new coronary angiographic scoring tool accommodating the variable coronary anatomy for the first time. Journal of Thoracic Disease Dec 2019; 11(12): 5199-5209.